F/M Emerald Life Sciences Innovation ETF (LFSC)

Assets	$59.15M
Expense Ratio	0.54%
PE Ratio	n/a
Shares Out	2.24M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	10,061
Open	25.06
Previous Close	25.39
Day's Range	24.99 - 25.06
52-Week Low	18.78
52-Week High	27.76
Beta	n/a
Holdings	35
Inception Date	Oct 31, 2024

About LFSC

Fund Home Page

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NASDAQ
• Ticker Symbol: LFSC
• ETF Provider: F/m Investments

Top 10 Holdings

53.47% of assets

Name	Symbol	Weight
BridgeBio Pharma, Inc.	BBIO	6.77%
Soleno Therapeutics, Inc.	SLNO	6.00%
RadNet, Inc.	RDNT	5.95%
LivaNova PLC	LIVN	5.69%
Travere Therapeutics, Inc.	TVTX	5.55%
TransMedics Group, Inc.	TMDX	5.43%
KalVista Pharmaceuticals, Inc.	KALV	5.11%
Collegium Pharmaceutical, Inc.	COLL	4.44%
Insmed Incorporated	INSM	4.37%
Merit Medical Systems, Inc.	MMSI	4.17%